Title | Creator | Description | Identifier | ||
---|---|---|---|---|---|
1 | Rituximab Use In Neurosarcoidosis | Mangayarkarasi Thandampallayam Ajjeya; David Kaufman; Lina Nagia | Rituximab is a chimeric monoclonal antibody that causes depletion of CD 20+ B cells. There are few documented reports describing successful use of rituximab in refractory neurosarcoidosis. Here we present a case of central nervous system (CNS) sarcoidosis effectively treated with rituximab. | 20180304_nanos_posters_037 |